Literature DB >> 6542445

A comparison of analgesia and suppression of oxytocin release by opiates.

G Clarke, D M Wright.   

Abstract

The potency of opiates for suppressing oxytocin release relative to their potency as analgesics was tested in lactating rats. Oxytocin release was evoked by the sucking of the young in urethane-anaesthetized and unanaesthetized rats, and was detected by the characteristic behaviour of the young and milk yield respectively. The tail-flick test, using noxious radiant heat, was used to assess analgesia. Intraperitoneal injection of morphine (1 mg kg-1 and 5 mg kg-1) significantly reduced milk yield in unanaesthetized rats. Urethane-anaesthetized rats displayed a pattern of reflex milk-ejection responses similar to that found in conscious rats. This reflex was significantly inhibited in a dose-related, naloxone-reversible manner by buprenorphine (ED50 0.18 mg kg-1), meptazinol (ED50: 14.0 mg kg-1), morphine (ED50: 0.67 mg kg-1), pentazocine (ED50: 15.0 mg kg-1) and pethidine (ED50: 7.9 mg kg-1). Although intraperitoneal injection of morphine (5 mg kg-1) abolished the increase in intramammary pressure occurring at reflex milk-ejection, that evoked by intravenous oxytocin (0.5-1 mu) was unaffected. Each opiate also caused significant, dose-related, naloxone-reversible increases in tail-flick latency. The ED50 doses were buprenorphine (ED50: 0.14 mg kg-1), meptazinol (ED50: 12.5 mg kg-1), morphine (ED50: 5.0 mg kg-1), pentazocine (ED50: 12.5 mg kg-1) and pethidine (ED50: 6.1 mg kg-1). The order of potency for analgesia and for suppression of oxytocin release were identical, namely: buprenorphine greater than morphine greater than pethidine greater than meptazinol greater than pentazocine. The results obtained with lactating rats suggest that secretion of the hormone oxytocin is substantially reduced during opiate-induced analgesia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6542445      PMCID: PMC1987075          DOI: 10.1111/j.1476-5381.1984.tb16235.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Opiate receptor binding in the pituitary gland.

Authors:  R Simantov; S H Snyder
Journal:  Brain Res       Date:  1977-03-18       Impact factor: 3.252

2.  A classification of opiate receptors that mediate antinociception in animals.

Authors:  M B Tyers
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

3.  Intermittent release of oxytocin during suckling in the rat.

Authors:  J B Wakerley; D W Lincoln
Journal:  Nat New Biol       Date:  1971-10-06

4.  Effect of ACTH on opiate inhibition of oxytocin release.

Authors:  D M Wright; C E Pill; G Clarke
Journal:  Life Sci       Date:  1983       Impact factor: 5.037

5.  Immunoreactive dynorphin in pituitary and brain.

Authors:  A Goldstein; V E Ghazarossian
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

6.  Opiate inhibition of peptide release from the neurohumoral terminals of hypothalamic neurones.

Authors:  G Clarke; P Wood; L Merrick; D W Lincoln
Journal:  Nature       Date:  1979-12-13       Impact factor: 49.962

7.  Effects of cholinoceptor antagonists on the suckling-induced and experimentally evoked release of oxytocin.

Authors:  G Clarke; C H Fall; D W Lincoln; L P Merrick
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739

8.  Agonist and antagonist properties of buprenorphine, a new antinociceptive agent.

Authors:  A Cowan; J W Lewis; I R Macfarlane
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

9.  Sleep: a prerequisite for reflex milk ejection in the rat.

Authors:  D W Lincoln; K Hentzen; T Hin; P van der Schoot; G Clarke; A J Summerlee
Journal:  Exp Brain Res       Date:  1980-01       Impact factor: 1.972

10.  Distribution of opioid peptides in the pituitary: a new hypothalamic-pars nervosa enkephalinergic pathway.

Authors:  J Rossier; Q Pittman; F Bloom; R Guillemin
Journal:  Fed Proc       Date:  1980-06
View more
  7 in total

1.  Naloxone potentiates the release of oxytocin induced by systemic administration of cholecystokinin without enhancing the electrical activity of supraoptic oxytocin neurones.

Authors:  G Leng; R E Dyball; S A Way
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

Review 2.  A guide to the safety of CNS-active agents during breastfeeding.

Authors:  C A Chisholm; J A Kuller
Journal:  Drug Saf       Date:  1997-08       Impact factor: 5.606

3.  Morphine actions on supraoptic oxytocin neurones in anaesthetized rats: tolerance after i.c.v. morphine infusion.

Authors:  K M Pumford; G Leng; J A Russell
Journal:  J Physiol       Date:  1991       Impact factor: 5.182

4.  Effects of morphine on catecholamine release and arrhythmias evoked by myocardial ischaemia in rats.

Authors:  K Addicks; H Hirche; F M McDonald; W Polwin
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

5.  Chronic intracerebroventricular morphine and lactation in rats: dependence and tolerance in relation to oxytocin neurones.

Authors:  V C Rayner; I C Robinson; J A Russell
Journal:  J Physiol       Date:  1988-02       Impact factor: 5.182

6.  Efficacy and Effects of Parenteral Pethidine or Meptazinol and Regional Analgesia for Pain Relief during Delivery. A Comparative Observational Study.

Authors:  J Singer; A Jank; S Amara; P D H Stepan; U Kaisers; C Hoehne
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-09       Impact factor: 2.915

7.  Plant parts substitution based approach as a viable conservation strategy for medicinal plants: A case study of Premna latifolia Roxb.

Authors:  Ashish Kumar Jena; Maninder Karan; Karan Vasisht
Journal:  J Ayurveda Integr Med       Date:  2017-03-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.